drugset / Trial / NCT03312426

An Investigational Study to Assess the Effect of a Light Meal and a High-Fat Meal on the Absorption of BMS-986205 in Healthy Participants

NCT03312426

Phase 1 Completed 32 enrolled Bristol-Myers Squibb
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to investigate the effect of a light meal and a high-fat meal on the bioavailability (absorption) of of BMS-986205 commercial tablet in healthy participants. Eligible participants will receive a single dose of BMS-986205 under fasted or fed (high-fat meal or light meal) conditions on Day 1 and Day 15. The safety, tolerability and movement of the BMS-986205 into, through and out of the body (pharmacokinetics/PK) under these conditions will be assessed.

Timeline

Start
2017-10-09
Primary completion
2017-11-22
Completion
2017-11-22

Drugs

EvaluationDrugModalityDoseRoute
Subject LINRODOSTAT Small molecule 100 mg

Indications

No indication recorded.